| Placebo, n (%)a | Pregabalin 150 mg/day, n (%)a | Pregabalin 300 mg/day, n (%)a | Pregabalin 600 mg/day, n (%)a |
---|---|---|---|---|
DPN | Â | Â | Â | Â |
   Age 18-64 y | 14 (3.8) | 3 (2.4) | 14 (7.7) | 42 (12.2) |
   Age 65-74 y | 12 (7.6) | 3 (7.7) | 9 (14.5) | 26 (18.7) |
   Age ≥75 y | 3 (8.8) | 1 (10.0) | 3 (13.6) | 7 (23.3) |
PHN | Â | Â | Â | Â |
   Age 18-64 y | 4 (5.9) | 5 (8.8) | 3 (6.7) | 12 (25.5) |
   Age 65-74 y | 11 (7.7) | 5 (5.4) | 8 (12.5) | 15 (21.7) |
   Age ≥75 y | 9 (5.9) | 11 (10.8) | 32 (26.4) | 13 (30.2) |